
4.54BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00650F1093
CUSIP
00650F109
Sector
Healthcare
Industry
Diagnostics & Research
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
1.09
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.45
Wall Street Target Price
33.86
EPS Estimate Current Year
-0.38
EPS Estimate Next Year
-0.05
EPS Estimate Current Quarter
-0.0955
EPS Estimate Next Quarter
-0.0641
Most Recent Quarter
-
Revenue TTM
298,009,984
Gross Profit TTM
137,803,008
EBITDA
-32,873,000
Profit Margin
-23.67%
Return On Assets TTM
-5.13%
Return On Equity TTM
-36.45%
Revenue Per Share TTM
1.895
Qtly Revenue Growth YOY
-10.70%
Diluted Eps TTM
-0.45
Qtly Earnings Growth YOY
-70.10%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
15.1714
Price Book MRQ
25.7541
Enterprise Value Revenue
15
Enterprise Value EBITDA
0
23.77
0.00%274.16
-5.81%440.45
-3.77%170.00
-3.35%221.32
-2.87%77.00
-2.70%673.31
-2.50%673.65
-2.44%775.12
-2.29%245.82
-1.80%